Increased oxidative DNA damage, lipid peroxidation, and reactive oxygen species in cultured orbital fibroblasts from patients with Graves’ ophthalmopathy: evidence that oxidative stress has a role in this disorder-Reference-Cited by-同舟云学术

Increased oxidative DNA damage, lipid peroxidation, and reactive oxygen species in cultured orbital fibroblasts from patients with Graves’ ophthalmopathy: evidence that oxidative stress has a role in this disorder

Published:2010-03-19 Issue:9 Volume:24 Page:1520-1525
ISSN:0950-222X
Container-title:Eye
language:en
Short-container-title:Eye

Author:

Tsai C-C,Wu S-B,Cheng C-Y,Kao S-C,Kau H-C,Chiou S-H,Hsu W-M,Wei Y-H

Publisher

Springer Science and Business Media LLC

Subject

Ophthalmology

Link

http://www.nature.com/articles/eye201031.pdf

Reference40 articles.

1. Bartalena L, Tanda ML . Clinical practice. Graves’ ophthalmopathy. N Engl J Med 2009; 360: 994–1001.

2. Kuriyan AE, Phipps RP, Feldon SE . The eye and thyroid disease. Curr Opin Ophthalmol 2008; 19: 499–506.

3. Bartalena L, Pinchera A, Marcocci C . Management of Graves’ ophthalmopathy: reality and perspectives. Endocr Rev 2000; 21: 168–199.

4. Kazim M, Goldberg RA, Smith TJ . Insights into the pathogenesis of thyroid associated orbitopathy: evolving rationale for therapy. Arch Ophthalmol 2002; 120: 380–386.

5. Prabhakar BS, Bahn RS, Smith TJ . Current perspective on the pathogenesis of Graves’ disease and ophthalmopathy. Endocr Rev 2003; 24: 802–835.

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Review of Pathophysiology and Therapeutic Strategies Targeting TGF-β in Graves’ Ophthalmopathy;Cells;2024-09-05

2. The efficacy and safety of selenium supplementation versus placebo in the treatment of Graves' orbitopathy: A systematic review and meta‐analysis of randomised controlled trials;Clinical Endocrinology;2024-08-13

3. Thyroid-associated ophthalmopathy: the role of oxidative stress;Frontiers in Endocrinology;2024-07-11

4. Redox mechanisms in autoimmune thyroid eye disease;Autoimmunity Reviews;2024-05

5. Changes of plasma cytokines content in Graves’ orbitopathy patients, could be potential markers;Environmental Disease;2024-04